David I Safferman, MD | |
7253 Ambassador Rd, Baltimore, MD 21244-2710 | |
(443) 436-1116 | |
(443) 436-1256 |
Full Name | David I Safferman |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 7253 Ambassador Rd, Baltimore, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285670919 | NPI | - | NPPES |
098311000 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | D0041398 (Maryland) | Primary |
Entity Name | Advanced Radiology Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932167178 PECOS PAC ID: 1254327950 Enrollment ID: O20040420001334 |
News Archive
A multi-institutional team of researchers has sequenced the DNA of 6,700 exomes, the portion of the genome that contains protein-coding genes, as part of the National Heart, Lung and Blood Institute (NHLBI)-funded Exome Sequencing Project, one of the largest medical sequencing studies ever undertaken.
Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.
Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.
Study findings refute the belief that patients with psychiatric illness may wait longer than is appropriate to see a doctor in the emergency department.
Bristol-Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the New Drug Application (NDA) for the investigational compound ixabepilone, an epothilone B analog.
› Verified 4 days ago
Entity Name | University Of Maryland Diagnostic Radiology, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467996959 PECOS PAC ID: 0345513248 Enrollment ID: O20170828004107 |
News Archive
A multi-institutional team of researchers has sequenced the DNA of 6,700 exomes, the portion of the genome that contains protein-coding genes, as part of the National Heart, Lung and Blood Institute (NHLBI)-funded Exome Sequencing Project, one of the largest medical sequencing studies ever undertaken.
Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.
Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.
Study findings refute the belief that patients with psychiatric illness may wait longer than is appropriate to see a doctor in the emergency department.
Bristol-Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the New Drug Application (NDA) for the investigational compound ixabepilone, an epothilone B analog.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
David I Safferman, MD 7253 Ambassador Rd, Baltimore, MD 21244-2710 Ph: (443) 436-1116 | David I Safferman, MD 7253 Ambassador Rd, Baltimore, MD 21244-2710 Ph: (443) 436-1116 |
News Archive
A multi-institutional team of researchers has sequenced the DNA of 6,700 exomes, the portion of the genome that contains protein-coding genes, as part of the National Heart, Lung and Blood Institute (NHLBI)-funded Exome Sequencing Project, one of the largest medical sequencing studies ever undertaken.
Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.
Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.
Study findings refute the belief that patients with psychiatric illness may wait longer than is appropriate to see a doctor in the emergency department.
Bristol-Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the New Drug Application (NDA) for the investigational compound ixabepilone, an epothilone B analog.
› Verified 4 days ago
Dr. Barun Aryal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3001 S Hanover St, Dept Of Internal Medicine, Baltimore, MD 21225 Phone: 410-350-3565 Fax: 410-354-0186 | |
Imran Ahmed, D.O Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Dept Of Radiology, Baltimore, MD 21201 Phone: 410-328-3477 | |
Michael Goldman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Saint Paul Pl, Radiology Dept, Baltimore, MD 21202 Phone: 410-332-9266 Fax: 410-545-4255 | |
Dr. Jeffrey R. Galvin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Dept Of Radiology, Baltimore, MD 21201 Phone: 410-328-3477 | |
Martin Auster, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-550-0214 | |
Amy K Pepperney, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7253 Ambassador Rd, Baltimore, MD 21244 Phone: 443-436-1151 Fax: 443-436-1256 | |
Carolyn Kwon, Radiology Medicare: May Accept Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-550-0100 |